Is AbbVie or Pfizer the better dividend-paying pharma stock?
The drugmaker reported that veliparib failed to outperform standard treatment in breast cancer and non-small-cell lung cancer trials.
Want high dividend yields? Check out healthcare stocks AbbVie, Pfizer, and Novo Nordisk.
AbbVie has a lot of things going for it, but the biotech faces some major risks.
Johnson & Johnson, Abbott Labs, AbbVie, Novo Nordisk, and Novartis rank as the top drug stocks with the best dividend track records.
These three stocks have attracted some of brightest investors in the world.
These three big pharma stocks offer compelling valuations and long-term growth trajectories.
Promising treatments could be on the way to address the diseases causing the most American deaths.
These three industries offer some of the cheapest stocks in the world.
AstraZeneca, Bristol-Myers Squibb, and Pfizer receive good news from the real world.